Form 4 for HUMA Humacyte, Inc.
Accepted 2022-12-13 00:00:00 ET · period of report 2022-12-12 · accession 0001818382-22-000203 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-13 | 2022-12-12 | HUMA | Prichard Heather Ledbetter | COO | M - OptEx | $1.15 | +6,564 | 9,189 | +250% | +$7,549 |
| D | 2022-12-13 | 2022-12-12 | HUMA | Prichard Heather Ledbetter | COO | M - OptEx | $0.00 | -6,564 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-12 | M | A | 6,564 | $1.15 | 9,189 | D | — | — | |
| 2 | Derivative | Stock Options (right to buy) | 2022-12-12 | M | D | 6,564 | $0.00 | 0 | D | $1.15 · 2015-12-14 to 2022-12-14 | 6,564 Common Stock |